Your browser doesn't support javascript.
loading
ImmunoPET: IMaging of cancer imMUNOtherapy targets with positron Emission Tomography: a phase 0/1 study characterising PD-L1 with 89Zr-durvalumab (MEDI4736) PET/CT in stage III NSCLC patients receiving chemoradiation study protocol.
Hegi-Johnson, Fiona; Rudd, Stacey E; Wichmann, Christian; Akhurst, Tim; Roselt, Peter; Trinh, Jenny; John, Thomas; Devereux, Lisa; Donnelly, Paul S; Hicks, Rod; Scott, Andrew M; Steinfort, Daniel; Fox, Stephen; Blyth, Benjamin; Parakh, Sagun; Hanna, Gerard G; Callahan, Jason; Burbury, Kate; MacManus, Michael.
Afiliação
  • Hegi-Johnson F; Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia fiona.hegi-johnson@petermac.org.
  • Rudd SE; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Wichmann C; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.
  • Akhurst T; Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg, Victoria, Australia.
  • Roselt P; School of Cancer Medicine, La Trobe University, Melbourne, Victoria, Australia.
  • Trinh J; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • John T; Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Devereux L; Cancer Imaging, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Donnelly PS; Radiation Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Hicks R; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Scott AM; Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Steinfort D; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Fox S; Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Blyth B; School of Chemistry and Bio21 Molecular Science and Biotechnology Institute, The University of Melbourne, Melbourne, Victoria, Australia.
  • Parakh S; The Department of Medicine, St Vincent's Medical School, University of Melbourne, Melbourne, Victoria, Australia.
  • Hanna GG; The Department of Medicine, Central Medical School, the Alfred Hospital, Monash University, Melbourne, Victoria, Australia.
  • Callahan J; Olivia Newton-John Cancer Research Institute, Austin Health, Heidelberg, Victoria, Australia.
  • Burbury K; Molecular Imaging and Therapy, The University of Melbourne Medicine at Austin Health, Heidelberg, Victoria, Australia.
  • MacManus M; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
BMJ Open ; 12(11): e056708, 2022 11 18.
Article em En | MEDLINE | ID: mdl-36400733
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Idioma: En Ano de publicação: 2022 Tipo de documento: Article